These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 16841484

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of parenteral or oral vinpocetine on the hemorheological parameters of patients with chronic cerebrovascular diseases.
    Feher G, Koltai K, Kesmarky G, Horvath B, Toth K, Komoly S, Szapary L.
    Phytomedicine; 2009 Mar; 16(2-3):111-7. PubMed ID: 19135345
    [Abstract] [Full Text] [Related]

  • 3. [About cavinton therapy of the patients with brain vascular diseases].
    Nikitina VV, Pravdina AN, Zapatrina OV.
    Voen Med Zh; 2007 Feb; 328(2):43-5. PubMed ID: 17508611
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Effect of cavinton on systemic and cerebral hemodynamics of patients with chronic cerebral circulatory insufficiency].
    Ishchenko MM, Shkrobot SI.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985 Feb; 85(9):1338-42. PubMed ID: 4072532
    [Abstract] [Full Text] [Related]

  • 7. [Use of cavinton in neuropaediatrics].
    Studenikin VM.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004 Feb; 104(12):63-4. PubMed ID: 15847328
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Effect of vinpocetin on the hemorheologic parameters in patients with chronic cerebrovascular disease].
    Szapáry L, Horváth B, Alexy T, Márton Z, Késmárky G, Szóts M, Nagy F, Czopf J, Tóth K.
    Orv Hetil; 2003 May 18; 144(20):973-8. PubMed ID: 12830727
    [Abstract] [Full Text] [Related]

  • 10. Vinpocetine and pyritinol: a new model for blood rheological modulation in cerebrovascular disorders—a randomized controlled clinical study.
    Alkuraishy HM, Al-Gareeb AI, Albuhadilly AK.
    Biomed Res Int; 2014 May 18; 2014():324307. PubMed ID: 25548768
    [Abstract] [Full Text] [Related]

  • 11. [Effect of cavinton and sulfocamphocain on systemic and cerebral hemodynamics in patients with early forms of cerebrovascular diseases].
    Ishchenko MM, Shkrobot SI, Borak VT.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987 May 18; 87(8):1160-4. PubMed ID: 3673409
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Therapeutic approach to TIA and acute cerebral stroke in geriatric patients using a platelet aggregation inhibiting and vasoactive drug].
    Cucinotta D, Monica C, Silvestrini C, Ceccato S, Cocchi C.
    G Clin Med; 1979 Apr 18; 60(4):301-9. PubMed ID: 488589
    [No Abstract] [Full Text] [Related]

  • 14. [Angiographic study of the action of pervincamine on cerebral circulation].
    Baiano G, Elefante R, Granata F, Graziussi G.
    Acta Neurol (Napoli); 1974 Mar 18; 29(2):185-9. PubMed ID: 4848048
    [No Abstract] [Full Text] [Related]

  • 15. [Diagnostics and treatment tactics for chronic cerebrovascular disorders with the use of single photon emission computed tomography].
    Murashko NK.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008 Mar 18; 108(1):51-5. PubMed ID: 18427520
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Cavinton forte treatment of cerebral vascular insufficiency in patients with coronary heart disease and arterial hypertension].
    Protasov KV, Dzizinskiĭ AA, Shprakh VV, Sinkevich DA, Kuklin SG, Filatova LN.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006 Mar 18; 106(7):31-4. PubMed ID: 16921716
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.